Received: 03 November 2021; Published on-line: 15 March 2022
Ocular hemodynamics in patients with posterior uveitis entities
N. I. Khramenko, N. V. Konovalova
SI "The Filatov Institute of Eye Diseases and Tissue Therapy of the NAMS of Ukraine"; Odesa (Ukraine)
TO CITE THIS ARTICLE: Khramenko N. I., Konovalova N. V. Ocular hemodynamics in patients with posterior uveitis entities. J.ophthalmol.(Ukraine).2022;1:11-9. http://doi.org/10.31288/oftalmolzh202211119
Background: In spite of recent advances in ophthalmology, the diagnosis and treatment of uveitis is still a challenge.
Purpose: To assess ocular hemodynamics in patients with primary and recurrent posterior uveitis (focal and disseminated chorioretinitis) using ophthalmic rheography.
Material and Methods: One hundred and eighteen patients (mean age ± standard deviation, 37.2 ± 1.5 years) with posterior uveitis were included in the study. The median duration of recurrent posterior uveitis was 2920 days (range, 1080 to 5110 days). The etiology of chorioretinitis was not established in all patients of the study. The age-matched control group was composed of 16 healthy volunteers (32 eyes). Patients and controls underwent ophthalmic rheography (ORG) with Reocom, the computerized rheography apparatus (Kharkiv, Ukraine). ORG included measurements of ocular pulse blood filling (expressed as RQ, ‰ rheographic coefficient) and vascular tone (expressed as alpha/T percentage index), and volumetric pulse blood filling rate (expressed as Ohm/s).
Results: In primary focal and disseminated chorioretinitis, inflammation was characterized by increased ocular circulation, which was manifested by (a) 20% increased ocular pulse blood filling (both for unilateral and bilateral inflammation); (b) 1.4-times and twice, respectively, increased volumetric pulse blood filling rate and (c) 12.5% and 33.3%, respectively, increased vascular tone in large-caliber vessels and small-caliber vessels. Ocular hemodynamics was increased in patients with unilateral recurrent focal, bilateral recurrent focal and bilateral recurrent disseminated chorioretinitis in the period of recurrence; particularly, ocular pulse blood filling was 17% increased, and volumetric pulse blood filling rate, 1.6 times increased. In addition, vascular tone in large-caliber vessels was increased. The period of remission in patients with focal chorioretinitis was characterized by normal ocular pulse blood filling, whereas in those with recurrent disseminated chorioretinitis, by 20% decreased ocular pulse blood filling compared to the norm. Volumetric pulse blood filling rate in the period or remission was 1.4-1.5-times increased in patients with focal chorioretinitis, but not in those with disseminated chorioretinitis.
Conclusion: Ocular pulse blood filling, volumetric pulse blood filling rate, and vascular tone in large-caliber and small-caliber vessels were increased in patients with primary posterior uveitis and those with recurrent posterior uveitis in the period of recurrence, both for unilateral and bilateral inflammation. In patients with recurrent posterior uveitis, the period of remission was characterized by a wide range of changes, from normal values to mild deficits, in ocular pulse blood filling, as well as increased vascular tone in vessels, which requires adequate anti-ischemic treatment in the period between recurrences.
Keywords: posterior uveitis entities, ophthalmic rheography, ocular hemodynamics
1.Tsirouki T, Dastiridou A, Symeonidis C, Tounakaki O, Brazitikou I, Kalogeropoulos C, et al. A Focus on the Epidemiology of Uveitis. Ocul Immunol Inflamm. 2018;26(1):2-16.
2.García-Aparicio Á, García de Yébenes MJ, Otón T, Muñoz-Fernández S. Prevalence and Incidence of Uveitis: A Systematic Review and Meta-analysis. Ophthalmic Epidemiol. 2021 Feb 8:1-8.
3.Zhang Y, Amin S, Lung KI, Seabury S, Rao N, Toy BC. Incidence, prevalence, and risk factors of infectious uveitis and scleritis in the United States: A claims-based analysis. PLoS One. 2020 Aug 25;15(8):e0237995.
4.Thorne JE, Suhler E, Skup M, Tari S, Macaulay D, Chao J, et al. Prevalence of noninfectious uveitis in the United States: A Claims-Based Analysis. JAMA Ophthalmol. 2016;134(11):1237–45.
5.Foster CS. Diagnosis and Treatment of Uveitis. 2nd ed. Jaypee Brothers Medical Publishers: New Delhi; 2013.
6.Nussenblatt RB, Whitcupp SM. Fundamentals and Clinical Practice. 4th ed. Philadelphia, PA: Mosby-Elsevier; 2010.
7.Lee JH, Mi H, Lim R, Ho SL, Lim WK, Teoh SC, et al. Ocular Autoimmune Systemic Inflammatory Infectious Study—Report 3: Posterior and Panuveitis. Ocul Immunol Inflamm. 2019;27(1):89–98.
8.Miserocchi E. Review on the world-wide epidemiology of uveitis. Eur J Ophthalmol. Sep-Oct 2013;23(5):705-17.
9.Katsnelson LA, Tankovskii VE. Uveitis: Clinical Features and Treatment. 2nd Updated and Revised Ed. Moscow: 4th Voenizdat Branch; 2003. Russian.
10.Venkataraman A, Rathinam SR, Venkataraman A. A pre- and post-treatment evaluation of vision-related quality of life in uveitis. Indian J Оphthalmol. Jul-Aug 2008;56(4):307-12.
11.Bloch-Michel E, Nussenblatt R.B. International uveitis study group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol. 1987 Feb 15;103(2):234-5.
12.Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005 Sep;140(3): 509–16.
13.Forrester JV, Kuffova JV, Forrester L, Dick AD. Autoimmunity, autoinflammation, and infection in uveitis. Am J Ophthalmol. 2018 May;189:77-85.
14.Avetisov SE, Sdobnikova SV, Surnina ZV, et al. [Idiopathic uveitis entities: new possibilities in the diagnosis (preliminary report)]. Point of View. East - West. 2018;4:8-9. Russian.
15.Agarwal A, Hassan M, Afridi R, et al. The role of optical coherence tomography angiography in the management of uveitis. Int Ophthalmol Clin. 2016;56(4):1–24.
16.Ushakova TM, Derezina TN, Poloziuk ON. [Pathological physiology: A manual for veterinary students]. Part 1. Persianovskii: Donskoi GAU; 2017. Russian.
17.Ado AD, editor. [Pathological physiology]. Moscow: Triada-Kh;2000. Russian.
18.Kim AY, Rodger DC, Shahidzadeh A, Chu Z, Koulisis N, Burkemper B, et al. Quantifying Retinal Microvascular Changes in Uveitis Using Spectral-Domain Optical Coherence Tomography Angiography. Am J Ophthalmol. 2016Nov;171:101-112.
19.Pichi F, Sarraf D, Arepalli S, Lowder CY, Cunningham ET Jr, Neri P, et al. The application of optical coherence tomography angiography in uveitis and inflammatory eye diseases. Prog Retin Eye Res. 2017 Jul;59:178-201
20.Karampelas M, Sim DA, Chu C, Carreno E, Keane PA, Zarranz-Ventura J, et al. Quantitative analysis of peripheral vasculitis, ischemia, and vascular leakage in uveitis using ultra-widefield fluorescein angiography. Am J Ophthalmol. 2015 Jun;159(6):1161-1168.e1.
21.Singh SR, Rasheed MA, Goud A, Sahoo NK, Vupparaboina KK, Chhablani J. Diurnal variation in subfoveal and peripapillary choroidal vascularity index in healthy eyes. Indian J Ophthalmol. 2019 Oct;67(10):1667-1672.
22.Konovalova NV, Khramenko NI, Shaibi A, Ivanitska OV, Naritsyna NI. [Optical coherence tomography study of the sensory retina and choroid in patients with uveitis]. Oftalmol Zh. 2014;3:34-41. Russian.
23.Konovalova NV, Khramenko NI, Shaibi A. [Optical coherence tomography study of the sensory retina and choroid in patients with uveitis]. Point of View. East - West. 2014;1:200-3. Russian.
24.Chu Z, Weinstein JE, Wang RK, Pepple KL. Quantitative Analysis of the Choriocapillaris in Uveitis Using En Face Swept-Source Optical Coherence Tomography Angiography. Am J Ophthalmol. 2020 Oct;218:17-27.
25.Feng X, Kedhar S, Bhoomibunchoo C. Retinal blood flow velocity in patients with active uveitis using the retinal function imager. Chin Med J (Engl). 2013;126(10):1944-7. 2013;126(10):1944-7.
26.Chudinova OV, Hokkanen VM. [Current possibilities of chorioretinites diagnostics]. Oftalmologiia. 2012;9(1):67-72. https://doi.org/10.18008/1816-5095-2012-1-67-72.
27.Khramenko NI, Konovalova NV. [Findings of ocular and brain hemodynamics in patients with anterior uveitis complicated by macular edema]. J Ophthalmol (Ukraine). 2020;4:С. 14-22.
Conflict of Interest Statement: The authors declare no conflicts of interest that could affect their opinion regarding the subject or materials described and discussed in this manuscript.